Veralox specializes in developing drugs to address unmet medical needs. It is currently working on therapies to target type 1 diabetes and a medication-induced immune disorder.
{iframe}https://www.bizjournals.com/baltimore/news/2019/09/05/frederick-biotech-veralox-therapeutics-raises-5-4.html{/iframe}